The DOI matches its Crossref record; 304 of the 304 references it cites were found in a registry or an index.
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
Open accessAbstract
INTRODUCTION: The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations. METHODS: The working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements. RESULTS: Participants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cheng, B.-Q., Jia, C.-Q., Liu, C.-T., Fan, W., Wang, Q.-L., Zhang, Z.-L., & Yi, C.-H. (2008) · JAMA · doi:10.1001/jama.299.14.1669 · Cited by 190
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Self-citationSorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Self-citationThalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
(2011) · Hepatogastroenterology · doi:10.5754/hge11125 · Cited by 2,450
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Wilhelm, S., Carter, C., Lynch, M., Lowinger, T., Dumas, J., Smith, R. A., Schwartz, B., Simantov, R., & Kelley, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2130 · Cited by 1,829
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
A prospective randomized trial
(1995) · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · doi:10.4030/jjcs1979.20.2_191 · Cited by 1,619
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Self-citationNonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Livraghi, T., Meloni, F., Di Stasi, M., Rolle, E., Solbiati, L., Tinelli, C., & Rossi, S. (2008) · Hepatology · doi:10.1002/hep.21933 · Cited by 1,103
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
Self-citationSurvival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,069
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
Lencioni, R. A., Allgaier, H.-P., Cioni, D., Olschewski, M., Deibert, P., Crocetti, L., Frings, H., Laubenberger, J., Zuber, I., Blum, H. E., et al. (2003) · Radiology · doi:10.1148/radiol.2281020718 · Cited by 998
Hepatic artery embolization in 120 patients with unresectable hepatoma.
Yamada, R., Sato, M., Kawabata, M., Nakatsuka, H., Nakamura, K., & Takashima, S. (1983) · Radiology · doi:10.1148/radiology.148.2.6306721 · Cited by 993
Varela, M., Real, M. I., Burrel, M., Forner, A., Sala, M., Brunet, M., Ayuso, C., Castells, L., Montañá, X., Llovet, J. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.020 · Cited by 941
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Kao, J., Chen, P., Lai, M., & Chen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70261-7 · Cited by 925
Self-citationGlypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
Capurro, M., Wanless, I. R., Sherman, M., Deboer, G., Shi, W., Miyoshi, E., & Filmus, J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00689-9 · Cited by 917
Jonas, S., Bechstein, W. O., Steinmüller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., & Neuhaus, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23561 · Cited by 894
Sunitinib: From Rational Design to Clinical Efficacy
Chow, L. Q. M., & Eckhardt, S. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.3602 · Cited by 883
Shiina, S., Teratani, T., Obi, S., Sato, S., Tateishi, R., Fujishima, T., Ishikawa, T., Koike, Y., Yoshida, H., Kawabe, T., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.009 · Cited by 877
Self-citationPower Doppler US: a potentially useful alternative to mean frequency-based color Doppler US.
Rubin, J. M., Bude, R. O., Carson, P. L., Bree, R. L., & Adler, R. S. (1994) · Radiology · doi:10.1148/radiology.190.3.8115639 · Cited by 867
Lencioni, R., Cioni, D., Crocetti, L., Franchini, C., Pina, C. D., Lera, J., & Bartolozzi, C. (2005) · Radiology · doi:10.1148/radiol.2343040350 · Cited by 867
Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
Poon, R. T.-P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00009 · Cited by 844
Self-citationNovel advancements in the management of hepatocellular carcinoma in 2008
Llovet, J. M., & Bruix, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.022 · Cited by 815
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Marelli, L., Stigliano, R., Triantos, C., Senzolo, M., Cholongitas, E., Davies, N., Tibballs, J., Meyer, T., Patch, D. W., & Burroughs, A. K. (2007) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-006-0062-3 · Cited by 791
Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases
Tateishi, R., Shiina, S., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., Yoshida, H., Kawabe, T., & Omata, M. (2005) · Cancer · doi:10.1002/cncr.20892 · Cited by 778
Self-citationGuidelines for Meta-analyses Evaluating Diagnostic Tests
Irwig, L., Tosteson, A. N. A., Gatsonis, C., Lau, J., Colditz, G., Chalmers, T. C., & Mosteller, F. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-8-199404150-00008 · Cited by 753
Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00002 · Cited by 733
Self-citationPoon, R. T.-P., Fan, S.-T., Ng, I. O.-L., Lo, C.-M., Liu, C.-L., & Wong, J. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<500::aid-cncr4>3.0.co;2-o · Cited by 729
Self-citationArii, S., Yamaoka, Y., Futagawa, S., Inoue, K., Kobayashi, K., Kojiro, M., Makuuchi, M., Nakamura, Y., Okita, K., & Yamada, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20456 · Cited by 725
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Poon, R. T., Fan, S. T., Lo, C. M., Liu, C. L., Lam, C. M., Yuen, W. K., Yeung, C., & Wong, J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141195.66155.0c · Cited by 677
Self-citationDonato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K. T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342402 · Cited by 668
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
Liebman, H. A., Furie, B. C., Tong, M. J., Blanchard, R. A., Lo, K.-J., Lee, S.-D., Coleman, M. S., & Furie, B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102204 · Cited by 617
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.003 · Cited by 609
Self-citationLin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2005) · Gut · doi:10.1136/gut.2004.045203 · Cited by 592
Self-citationYeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., Koh, J., Mo, F. K. F., Yu, S. C. H., Chan, A. T., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji315 · Cited by 590
Centre for Evidence Based Medicine
Badenoch, D., & Mbe (2003) · Cited by 586
Yuen, M.-F., Tanaka, Y., Fong, D. Y.-T., Fung, J., Wong, D. K.-H., Yuen, J. C.-H., But, D. Y.-K., Chan, A. O.-O., Wong, B. C.-Y., Mizokami, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.023 · Cited by 584
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Yeh, S.-H., Chen, P.-J., Iloeje, U. H., Jen, C.-L., Su, J., Wang, L.-Y., Lu, S.-N., You, S.-L., Chen, D.-S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn243 · Cited by 580
Self-citationShibata, T., Iimuro, Y., Yamamoto, Y., Maetani, Y., Ametani, F., Itoh, K., & Konishi, J. (2002) · Radiology · doi:10.1148/radiol.2232010775 · Cited by 575
Chemoembolization for hepatocellular carcinoma
Bruix, J., Sala, M., & Llovet, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.032 · Cited by 569
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Self-citationPoon, R. T.-P., Fan, S.-T., Lo, C.-M., Liu, C.-L., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199902000-00009 · Cited by 550
Self-citationChen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 549
Self-citationColli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., & Duca, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00467.x · Cited by 540
Kao, J., Chen, P., Lai, M., & Chen, D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50053 · Cited by 536
Self-citationYao, F. Y., Kerlan, R. K., Hirose, R., Davern, T. J., Bass, N. M., Feng, S., Peters, M., Terrault, N., Freise, C. E., Ascher, N. L., et al. (2008) · Hepatology · doi:10.1002/hep.22412 · Cited by 513
Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., Chen, H., Clark-Garvey, S., Weinberg, A., Mandeli, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9947 · Cited by 506
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
Varnum, B. C., Young, C., Elliott, G., Garcia, A., Bartley, T. D., Fridell, Y.-W., Hunt, R. W., Trail, G., Clogston, C., Toso, R. J., et al. (1995) · Nature · doi:10.1038/373623a0 · Cited by 481
Epidemiological characteristics and risk factors of hepatocellular carcinoma
CHEN, C., YU, M., & LIAW, Y. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00513.x · Cited by 470
Self-citationIkeda, K., Saitoh, S., Arase, Y., Chayama, K., Suzuki, Y., Kobayashi, M., Tsubota, A., Kobayashi, M., Nakamura, I., Murashima, N., et al. (1999) · Hepatology · doi:10.1002/hep.510290439 · Cited by 467
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
Torzilli, G. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.9.984 · Cited by 455
Bolondi, L., Gaiani, S., Celli, N., Golfieri, R., Grigioni, W. F., Leoni, S., Venturi, A. M., & Piscaglia, F. (2005) · Hepatology · doi:10.1002/hep.20728 · Cited by 451
Adult-to-Adult Transplantation of the Right Hepatic Lobe from a Living Donor
Trotter, J. F., Wachs, M., Everson, G. T., & Kam, I. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011629 · Cited by 451
Burrel, M., Llovet, J. M., Ayuso, C., Iglesias, C., Sala, M., Miquel, R., Caralt, T., Ayuso, J. R., Solé, M., Sanchez, M., et al. (2003) · Hepatology · doi:10.1002/hep.1840380430 · Cited by 451
坂元, 亨. (1991) · Medical Entomology and Zoology · doi:10.11501/3086943 · Cited by 448
Lin, S.-M., Sheen, I.-S., Chien, R.-N., Chu, C.-M., & Liaw, Y.-F. (1999) · Hepatology · doi:10.1002/hep.510290312 · Cited by 444
Self-citationSakamoto, M., Hirohashi, S., & Shimosato, Y. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90039-r · Cited by 442
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
Sato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., Taketa, K., Endo, Y., & Nagataki, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282502 · Cited by 439
Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., & Omata, M. (1995) · Hepatology · doi:10.1002/hep.1840210308 · Cited by 432
Self-citationEnvironmental factors and risk for hepatocellular carcinoma
Yu, M. C., & Yuan, J.-M. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.018 · Cited by 426
Screening for hepatocellular carcinoma
Collier, J., & Sherman, M. (1998) · Hepatology · doi:10.1002/hep.510270140 · Cited by 425
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma
Khan, M. A., Combs, C. S., Brunt, E. M., Lowe, V. J., Wolverson, M. K., Solomon, H., Collins, B. T., & Bisceglie, A. M. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80248-2 · Cited by 417
Resection Prior to Liver Transplantation for Hepatocellular Carcinoma
Belghiti, J., Cortes, A., Abdalla, E. K., Régimbeau, J.-M., Prakash, K., Durand, F., Sommacale, D., Dondero, F., Lesurtel, M., Sauvanet, A., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000098621.74851.65 · Cited by 415
Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan†
Ikai, I., Arii, S., Okazaki, M., Okita, K., Omata, M., Kojiro, M., Takayasu, K., Nakanuma, Y., Makuuchi, M., Matsuyama, Y., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00119.x · Cited by 412
Self-citationInfluence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M., & Saisho, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50036 · Cited by 403
Determinants of outcome of compensated hepatitis C virus-related cirrhosis
Serfaty, L., Aumaître, H., Chazouillères, O., Bonnand, A.-M., Rosmorduc, O., Poupon, R. E., & Poupon, R. Y. (1998) · Hepatology · doi:10.1002/hep.510270535 · Cited by 403
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Zhu, A. X., Blaszkowsky, L. S., Ryan, D. P., Clark, J. W., Muzikansky, A., Horgan, K., Sheehan, S., Hale, K. E., Enzinger, P. C., Bhargava, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9130 · Cited by 388
Marrero, J. A., Su, G. L., Wei, W., Emick, D., Conjeevaram, H. S., Fontana, R. J., & Lok, A. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50195 · Cited by 387
Patterns of Recurrence After Initial Treatment in Patients With Small Hepatocellular Carcinoma
Kumada, T., Nakano, S., Takeda, I., Sugiyama, K., Osada, T., Kiriyama, S., Sone, Y., Toyoda, H., Shimada, S., Takahashi, M., et al. (1997) · Hepatology · doi:10.1002/hep.510250116 · Cited by 378
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Shiina, S., Tagawa, K., Niwa, Y., Unuma, T., Komatsu, Y., Yoshiura, K., Hamada, E., Takahashi, M., Shiratori, Y., & Terano, A. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.160.5.7682378 · Cited by 370
Self-citationCastells, A., Bruix, J., Bru, C., Fuster, J., Vilana, R., Navasa, M., Ayuso, C., Boix, L., Visa, J., & Rodés, J. (1993) · Hepatology · doi:10.1002/hep.1840180517 · Cited by 368
Mazzaferro, V., Romito, R., Schiavo, M., Mariani, L., Camerini, T., Bhoori, S., Capussotti, L., Calise, F., Pellicci, R., Belli, G., et al. (2006) · Hepatology · doi:10.1002/hep.21415 · Cited by 367
Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Kanai, F., Okudaira, T., Teratani, T., Tohgo, G., Toda, N., Ohashi, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840220403 · Cited by 365
Self-citationHepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Significance of Resection Margin in Hepatectomy for Hepatocellular Carcinoma: A Critical Reappraisal
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00014 · Cited by 357
Self-citationSherman, M., Peltekian, K. M., & Lee, C. (1995) · Hepatology · doi:10.1002/hep.1840220210 · Cited by 357
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Cammà, C., Giunta, M., Andreone, P., & Craxı̀, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00005-8 · Cited by 356
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
&NA; (1994) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199412000-00009 · Cited by 356
Ikeda, K., Arase, Y., Saitoh, S., Kobayashi, M., Suzuki, Y., Suzuki, F., Tsubota, A., Chayama, K., Murashima, N., & Kumada, H. (2000) · Hepatology · doi:10.1053/jhep.2000.9409 · Cited by 354
Kuper, H., Tzonou, A., Kaklamani, E., Hsieh, C.-C., Lagiou, P., Adami, H.-O., Trichopoulos, D., & Stuver, S. O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<498::aid-ijc9>3.0.co;2-f · Cited by 350
LOPEZ, P. M., VILLANUEVA, A., & LLOVET, J. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02932.x · Cited by 344
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells
Yanagisawa, K., Moriyasu, F., Miyahara, T., Yuki, M., & Iijima, H. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.08.008 · Cited by 343
Grazi, G. L., Ercolani, G., Pierangeli, F., Del Gaudio, M., Cescon, M., Cavallari, A., & Mazziotti, A. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00011 · Cited by 341
Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan
Chen, D. (1996) · JAMA · doi:10.1001/jama.276.11.906 · Cited by 339
Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Imai, Y., Kawata, S., Tamura, S., Yabuuchi, I., Noda, S., Inada, M., Maeda, Y., Shirai, Y., Fukuzaki, T., Kaji, I., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00005 · Cited by 338
Chen, D.-S. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390190075023 · Cited by 333
Krinsky, G. A., Lee, V. S., Theise, N. D., Weinreb, J. C., Rofsky, N. M., Diflo, T., & Teperman, L. W. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma40445 · Cited by 332
McMahon, B. J., Bulkow, L., Harpster, A., Snowball, M., Lanier, A., Sacco, F., Dunaway, E., & Williams, J. (2000) · Hepatology · doi:10.1053/jhep.2000.17914 · Cited by 327
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B
van Zonneveld, M., Honkoop, P., Hansen, B. E., Niesters, H. G. M., Murad, S. D., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20128 · Cited by 322
Heiken, J. P., Weyman, P. J., Lee, J. K., Balfe, D. M., Picus, D., Brunt, E. M., & Flye, M. W. (1989) · Radiology · doi:10.1148/radiology.171.1.2538862 · Cited by 315
Self-citationMuto, Y., Moriwaki, H., & Shiratori, Y. (1998) · Digestion · doi:10.1159/000051435 · Cited by 315
Koike, Y., Shiratori, Y., Sato, S., Obi, S., Teratani, T., Imamura, M., Yoshida, H., Shiina, S., & Omata, M. (2001) · Cancer · doi:10.1002/1097-0142(20010201)91:3<561::aid-cncr1035>3.0.co;2-n · Cited by 310
Self-citationPhase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
Thomas, M. B., Chadha, R., Glover, K., Wang, X., Morris, J., Brown, T., Rashid, A., Dancey, J., & Abbruzzese, J. L. (2007) · Cancer · doi:10.1002/cncr.22886 · Cited by 306
Chan, H. L.-Y., Tse, C.-H., Mo, F., Koh, J., Wong, V. W.-S., Wong, G. L.-H., Lam Chan, S., Yeo, W., Sung, J. J.-Y., & Mok, T. S.-K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2043 · Cited by 301
Taketa, K., Endo, Y., Sekiya, C., Tanikawa, K., Kōji, T., Taga, H., Satomura, S., Matsuura, S., Kawai, T., & Hirai, H. (1993) · PubMed · Cited by 297
Hippo, Y., Watanabe, K., Watanabe, A., Midorikawa, Y., Yamamoto, S., Ihara, S., Tokita, S., Iwanari, H., Ito, Y., Nakano, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2191 · Cited by 297
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., & Beaugrand, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80468-4 · Cited by 296
Rode, A., Bancel, B., Douek, P., Chevallier, M., Vilgrain, V., Picaud, G., Henry, L., Berger, F., Bizollon, T., Gaudin, J.-L., et al. (2001) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200105000-00001 · Cited by 292
Zhu, Z.-W., Friess, H., Wang, L., Abou-Shady, M., Zimmermann, A., Lander, A. D., Korc, M., Kleeff, J., & Büchler, M. W. (2001) · Gut · doi:10.1136/gut.48.4.558 · Cited by 291
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
Yao, F. Y., Hirose, R., LaBerge, J. M., Davern, T. J., Bass, N. M., Kerlan, R. K., Merriman, R., Feng, S., Freise, C. E., Ascher, N. L., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20526 · Cited by 288
Neoangiogenesis and Sinusoidal "Capillarization" in Dysplastic Nodules of the Liver
Park, Y. N., Yang, C.-P., Fernandez, G. J., Cubukcu, O., Thung, S. N., & Theise, N. D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199806000-00002 · Cited by 285
Shiratori, Y., Ito, Y., Yokosuka, O., Imazeki, F., Nakata, R., Tanaka, N., Arakawa, Y., Hashimoto, E., Hirota, K., Yoshida, H., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00009 · Cited by 282
Self-citationAflatoxins as risk factors for hepatocellular carcinoma in humans.
Wogan, G. N. (1992) · PubMed · Cited by 280
Gish, R. G., Porta, C., Lazar, L., Ruff, P., Feld, R., Croitoru, A., Feun, L., Jeziorski, K., Leighton, J., Knox, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4046 · Cited by 279
Livraghi, T., Bolondi, L., Buscarini, L., Cottone, M., Mazziotti, A., Morabito, A., & Torzilli, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80445-5 · Cited by 278
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma
Trojan, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00603-6 · Cited by 277
Ruhl, C. E., & Everhart, J. E. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.075 · Cited by 275
Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00647.x · Cited by 275
Shiratori, Y., Shiina, S., Teratani, T., Imamura, M., Obi, S., Sato, S., Koike, Y., Yoshida, H., & Omata, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00008 · Cited by 274
Self-citationCancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273 · cited 1×
“Two such studies from the United States and Sweden showed a strong association of HCC and HH [64, 135].”
BackgroundStrickland, T. G. (2006) · Hepatology · doi:10.1002/hep.21173 · Cited by 272
Chemoembolization of Hepatocellular Carcinoma
Ramsey, D. E., Kernagis, L. Y., Soulen, M. C., & Geschwind, J.-F. H. (2002) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(07)61789-8 · Cited by 271
Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9)
Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S. R., Monna, T., Kobayashi, K., & Tango, T. (1995) · Cancer · doi:10.1002/1097-0142(19950901)76:5<743::aid-cncr2820760506>3.0.co;2-v · Cited by 269
Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma
Muto, Y., Moriwaki, H., & Saito, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401315 · Cited by 265
Miyayama, S., Matsui, O., Yamashiro, M., Ryu, Y., Kaito, K., Ozaki, K., Takeda, T., Yoneda, N., Notsumata, K., Toya, D., et al. (2007) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2006.12.004 · Cited by 260
Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?
Zhu, A. X. (2006) · The Oncologist · doi:10.1634/theoncologist.11-7-790 · Cited by 260
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
Wang, L.-Y., Hatch, M., Chen, C.-J., Levin, B., You, S.-L., Lu, S.-N., Wu, M.-H., Wu, W.-P., Wang, L.-W., Wang, Q., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<620::aid-ijc5>3.0.co;2-w · Cited by 259
Arguedas, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06049-5 · Cited by 252
Kubo, S., Nishiguchi, S., Hirohashi, K., Tanaka, H., Shuto, T., Yamazaki, O., Shiomi, S., Tamori, A., Oka, H., Igawa, S., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00010 · Cited by 251
Chen, C.-J., Liang, K.-Y., Chang, A.-S., Chang, Y.-C., Lu, S.-N., Liaw, Y.-F., Chang, W.-Y., Sheen, M.-C., & Lin, T.-M. (1991) · Hepatology · doi:10.1002/hep.1840130303 · Cited by 247
Self-citationPhase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
Zhu, A. X., Stuart, K., Blaszkowsky, L. S., Muzikansky, A., Reitberg, D. P., Clark, J. W., Enzinger, P. C., Bhargava, P., Meyerhardt, J. A., Horgan, K., et al. (2007) · Cancer · doi:10.1002/cncr.22829 · Cited by 246
Papatheodoridis, G. V., Manesis, E., & Hadziyannis, S. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00094-5 · Cited by 246
Ng, K. K., Vauthey, J.-N., Pawlik, T. M., Lauwers, G. Y., Regimbeau, J.-M., Belghiti, J., Ikai, I., Yamaoka, Y., Curley, S. A., Nagorney, D. M., et al. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.06.004 · Cited by 241
Self-citationSeroepidemiology of Hepatitis B Virus Infection in Children: Ten Years of Mass Vaccination in Taiwan
Chen, H.-L. (1996) · JAMA · doi:10.1001/jama.1996.03540110060032 · Cited by 241
(1997) · PubMed · Cited by 239
Bräu, N., Fox, R. K., Xiao, P., Marks, K., Naqvi, Z., Taylor, L. E., Trikha, A., Sherman, M., Sulkowski, M. S., Dieterich, D. T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.010 · Cited by 239
Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
Nishiguchi, S., Shiomi, S., Nakatani, S., Takeda, T., Fukuda, K., Tamori, A., Habu, D., & Tanaka, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03595-9 · Cited by 238
Effects of Sho–Saiko–To, A Japanese Herbal Medicine, on Hepatic Fibrosis in Rats
Shimizu, I., Ma, Y.-R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., et al. (1999) · Hepatology · doi:10.1002/hep.510290108 · Cited by 236
Pawlik, T. M., Poon, R. T., Abdalla, E. K., Ikai, I., Nagorney, D. M., Belghiti, J., Kianmanesh, R., Oi-Lin Ng, I., Curley, S. A., Yamaoka, Y., et al. (2005) · Surgery · doi:10.1016/j.surg.2004.12.012 · Cited by 235
Self-citationFamilial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives
Yu, M.-W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1159 · Cited by 235
Sun, C.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg041 · Cited by 234
Yuen, M.-F., Hui, C.-K., Cheng, C.-C., Wu, C.-H., Lai, Y.-P., & Lai, C.-L. (2001) · Hepatology · doi:10.1053/jhep.2001.25273 · Cited by 232
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200104000-00030 · Cited by 232
Marrero, J. A., Hussain, H. K., Nghiem, H. V., Umar, R., Fontana, R. J., & Lok, A. S. (2005) · Liver Transplantation · doi:10.1002/lt.20357 · Cited by 231
Chen, C., Hung, C., Lee, C., Hu, T., Wang, J., Wang, J., Lu, S., & Changchien, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.002 · Cited by 231
Yoshizawa, H. (2002) · Oncology · doi:10.1159/000048270 · Cited by 229
Coffee drinking and hepatocellular carcinoma risk: A meta‐analysis†
Bravi, F., Bosetti, C., Tavani, A., Bagnardi, V., Gallus, S., Negri, E., Franceschi, S., & La Vecchia, C. (2007) · Hepatology · doi:10.1002/hep.21708 · Cited by 227
Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.9113 · Cited by 223
Coffee consumption and risk of liver cancer: A meta-analysis
Larsson, S. C., & Wolk, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.044 · Cited by 218
Lampertico, P., Del Ninno, E., Viganò, M., Romeo, R., Donato, M. F., Sablon, E., Morabito, A., & Colombo, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50148 · Cited by 215
Evans, A. A., Chen, G., Ross, E. A., Shen, F., Lin, W., & London, W. T. (2002) · PubMed · Cited by 208
Ebara, M., Okabe, S., Kita, K., Sugiura, N., Fukuda, H., Yoshikawa, M., Kondo, F., & Saisho, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.033 · Cited by 208
Patt, Y. Z., Hassan, M. M., Aguayo, A., Nooka, A. K., Lozano, R. D., Curley, S. A., Vauthey, J., Ellis, L. M., Schnirer, I. I., Wolff, R. A., et al. (2004) · Cancer · doi:10.1002/cncr.20368 · Cited by 203
Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma
Kaklamani, E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460150078027 · Cited by 201
Jang, J. W., Choi, J. Y., Bae, S. H., Yoon, S. K., Chang, I. U., Kim, C. W., Cho, S. H., Han, J. Y., & Lee, Y. S. (2006) · Hepatology · doi:10.1002/hep.21024 · Cited by 198
Kudo, M., & Okanoue, T. (2007) · Oncology · doi:10.1159/000111702 · Cited by 196
Self-citationHepatitis B Vaccination and Hepatocellular Carcinoma Rates in Boys and Girls
Chang, M.-H. (2000) · JAMA · doi:10.1001/jama.284.23.3040 · Cited by 196
Louafi, S., Boige, V., Ducreux, M., Bonyhay, L., Mansourbakht, T., de Baere, T., Asnacios, A., Hannoun, L., Poynard, T., & Taïeb, J. (2007) · Cancer · doi:10.1002/cncr.22532 · Cited by 195
(1985) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/75.1.81 · Cited by 195
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
Tateishi, R., Yoshida, H., Matsuyama, Y., Mine, N., Kondo, Y., & Omata, M. (2008) · Hepatology International · doi:10.1007/s12072-007-9038-x · Cited by 194
Self-citationTranscatheter and Ablative Therapeutic Approaches for Solid Malignancies
Liapi, E., & Geschwind, J.-F. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8657 · Cited by 191
Yu, M. C., Henderson, B. E., Tong, M. J., & Govindarajan, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1820 · Cited by 190
Stasi, M. D., Buscarini, L., Livraghi, T., Giorgoi, A., Salmi, A., Sio, I. D., Brunello, F., Solmi, L., Caturelli, E., Magnolfi, F., et al. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709002998 · Cited by 188
Resolution of acute hepatitis C after therapy with natural beta interferon
Omata, M., Yokosuka, O., Takano, S., Kato, N., Hosoda, K., Imazeki, F., Tada, M., Ito, Y., & Ohto, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91774-o · Cited by 187
Self-citationLee, C.-M., Lu, S.-N., Changchien, C.-S., Yeh, C.-T., Hsu, T.-T., Tang, J.-H., Wang, J.-H., Lin, D.-Y., Chen, C.-L., & Chen, W.-J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991001)86:7<1143::aid-cncr7>3.0.co;2-z · Cited by 186
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
Ishii, H., Okada, S., Nose, H., Okusaka, T., Yoshimori, M., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., & Hirohashi, S. (1996) · Cancer · Cited by 184
Shiina, S., Teratani, T., Obi, S., Hamamura, K., Koike, Y., & Omata, M. (2002) · Oncology · doi:10.1159/000048278 · Cited by 183
Self-citationCottone, M., Turri, M., Caltagirone, M., Parisi, P., Orlando, A., Fiorentino, G., Virdone, R., Fusco, G., Grasso, R., Simonetti, R. G., et al. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80613-0 · Cited by 179
Yu, M. C., Tong, M. J., Coursaget, P., Ross, R. K., Govindarajan, S., & Henderson, B. E. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.12.1038 · Cited by 175
Hepatocellular carcinoma in the thalassaemia syndromes
Borgna‐Pignatti, C., Vergine, G., Lombardo, T., Cappellini, M. D., Cianciulli, P., Maggio, A., Renda, D., Lai, M. E., Mandas, A., Forni, G., et al. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04732.x · Cited by 174
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Self-citationOmata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Self-citationGlobal patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Self-citationChernyak, V., Fowler, K. J., Kamaya, A., Kielar, A. Z., Elsayes, K. M., Bashir, M. R., Kono, Y., Do, R. K., Mitchell, D. G., Singal, A. G., et al. (2018) · Radiology · doi:10.1148/radiol.2018181494 · Cited by 1,152
Bruix, J., Takayama, T., Mazzaferro, V., Chau, G.-Y., Yang, J., Kudo, M., Cai, J., Poon, R. T., Han, K.-H., Tak, W. Y., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00198-9 · Cited by 1,120
Self-citation
Metadata
- Authors
- Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., Shiina, S., Cheng, A. L., Jia, J.-D., Obi, S., Han, K. H., Jafri, W., Chow, P., Lim, S. G., Chawla, Y. K., Budihusodo, U., Gani, R. A., Lesmana, C. R., Putranto, T. A., Liaw, Y. F., & Sarin, S. K.
- Venue
- Hepatology International
- Published
- 2010-03-18
- Volume
- 4
- Issue
- 2
- Pages
- 439-474
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- OpenAlex
- W2047554241
- Cited by
- 1,026
- References
- 304
- FWCI
- 29.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.